Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Barbro Eriksson"'
Autor:
Kazhan Mollazadegan, Britt Skogseid, Johan Botling, Tobias Åkerström, Barbro Eriksson, Staffan Welin, Anders Sundin, Joakim Crona
Publikováno v:
Endocrine Connections, Vol 11, Iss 3, Pp 1-8 (2022)
Longitudinal changes in pancreatic neuroendocrine tumor (panNET) cell proliferation correlate with fast disease progression and poor prognosis. The optimal treatment strategy for secondary panNET grade (G)3 that has progressed from a previous low-or
Externí odkaz:
https://doaj.org/article/06dbeab2e1c241028a2dab8cd387288b
Autor:
Lina Carlbom, José Caballero-Corbalán, Dan Granberg, Jens Sörensen, Barbro Eriksson, Håkan Ahlström
Publikováno v:
Upsala Journal of Medical Sciences, Vol 122, Iss 1, Pp 43-50 (2017)
Aim: We wanted to explore if whole-body magnetic resonance imaging (MRI) including diffusion-weighted (DW) and liver-specific contrast agent-enhanced imaging could be valuable in lesion detection of neuroendocrine tumors (NET). [11C]-5-Hydroxytryptop
Externí odkaz:
https://doaj.org/article/dda516c5ee064710aa8f51b5859df7ff
Autor:
Kazhan Mollazadegan, Britt Skogseid, Johan Botling, Tobias AEkerstrom, Barbro Eriksson, Staffan Welin, Sundin Anders, Joakim Crona
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eab117ea82b0c5709d45b72e39a50386
https://doi.org/10.1530/endoabs.81.ep587
https://doi.org/10.1530/endoabs.81.ep587
Autor:
Gökçe Kilinçalp, Anne-Christine Sjöström, Barbro Eriksson, Björn Holmberg, Radu Constantinescu, Filip Bergquist
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 1; Pages: 27
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 12, Iss 27, p 27 (2022)
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 12, Iss 27, p 27 (2022)
Patients with Parkinson’s disease that may benefit from device-assisted therapy can be identified with guidelines like Navigate PD. The decision to offer advanced treatment and the choice of treatment modality are, however, not straightforward, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce04b5d8e9a0fcd66d94467ce12c859e
Publikováno v:
Endocrine pathology. 2(3)
A 50-year-old man developed a pancreatic islet tumor with liver metastases. High levels of islet amyloid polypeptide (IAPP) were recorded in plasma-35,000 pmol/L-concomitant with the occurrence of type II diabetes mellitus (the clinical syndrome has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adf054faec4e67e1bb40c38c820fd2b7
https://pubmed.ncbi.nlm.nih.gov/32357646
https://pubmed.ncbi.nlm.nih.gov/32357646
Autor:
Rolf Håkanson, L. I. Larsson, Jan Alumets, G Lundquist, Frank Sundler, Kjell Öberg, Barbro Eriksson
Publikováno v:
Endocrine pathology. 3(1)
Certain proteins, such as the chromogranins, have a ubiquitous occurrence in nearly ail peptide hormone-producing cells. To date, little is known about their functional role as structural proteins, precursors of bioactive peptides, or enzymes. Such p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d332a32786ffc20870c4425c94ed0d
https://pubmed.ncbi.nlm.nih.gov/32138402
https://pubmed.ncbi.nlm.nih.gov/32138402
Autor:
Cecilia Wassberg, Britt Skogseid, Pantelis Antonodimitrakis, Dan Granberg, Barbro Eriksson, Anders Sundin, Helena Olofsson, Lars Grimelius
Publikováno v:
International Journal of Endocrine Oncology. 4:9-22
Aim: Vasoactive intestinal polypeptide producing neuroendocrine tumors are rare and cause severe hormonal symptoms. Patients/methods: Eighteen patients with vasoactive intestinal polypeptide producing neuroendocrine tumors were analyzed with reviews
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7954a6d7c71e701b681181ee0eb10f0a
https://doi.org/10.2217/ije-2016-0012
https://doi.org/10.2217/ije-2016-0012
Autor:
Olov Norlén, Staffan Welin, Pantelis Antonodimitrakis, Peter Stålberg, Barbro Eriksson, Joakim Crona
Publikováno v:
Pancreas. 46:427-451
Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4aedfa52dd6c8bc4bfc4723e1905b63
https://doi.org/10.1097/mpa.0000000000000812
https://doi.org/10.1097/mpa.0000000000000812
Publikováno v:
Anticancer Research. 37:705-712
Mutations affecting the mechanistic target of rapamycin (MTOR) signalling pathway are frequent in human cancer and have been identified in up to 15% of pancreatic neuroendocrine tumours (NETs). Grade A evidence supports the efficacy of MTOR inhibitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a99143315b9c4e7075d8d79de224dc
https://doi.org/10.21873/anticanres.11367
https://doi.org/10.21873/anticanres.11367
Autor:
Katarzyna, Fröss-Baron, Ulrike, Garske-Roman, Staffan, Welin, Dan, Granberg, Barbro, Eriksson, Tanweera, Khan, Mattias, Sandström, Anders, Sundin
Publikováno v:
Neuroendocrinology. 111(4)
To retrospectively analyze toxicity, progression-free survival (PFS), overall survival (OS), and their determinants in patients with advanced pancreatic neuroendocrine tumors (PanNETs), previously pretreated with chemothe-r-apy, undergoing peptide re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e0f435bd8ac4e042228056af3beaf06
https://pubmed.ncbi.nlm.nih.gov/32097917
https://pubmed.ncbi.nlm.nih.gov/32097917